NewsBenzingaNovoCure、2026年度売上高見通しを7億1,000万~7億2,500万ドルから7億3,600万~7億4,300万ドルに引き上げ 予想7億2,581.4万ドルを上回る NovoCure、2026年度売上高見通しを7億1,000万~7億2,500万ドルから7億3,600万~7億4,300万ドルに引き上げ 予想7億2,581.4万ドルを上回る Benzinga 2026.10.29 11:00 (GMT+0) Open on Benzinga Other news Swoosh and a Miss: Nike Investor Day Leaves Wall Street Cold-Footed Wall Street Says the AI Trade Is Over — ETF Investors Aren’t Acting Like It Citigroup Maintains Neutral on Westlake, Lowers Price Target to $65 Citigroup Maintains Neutral on LyondellBasell Industries, Lowers Price Target to $66 Caterpillar's 'Best-In-Class' Construction Business Is Getting Overlooked, Analyst Says How to Play NKE Stock as Nike Risks Becoming a Forever Turnaround Story